These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31916319)

  • 1. Prediction models for the viability of pulmonary metastatic lesions after chemotherapy in nonseminomatous germ cell tumors.
    Tsunezuka H; Nakamura T; Fujikawa K; Shimomura M; Okada S; Shimada J; Teramukai S; Ukimura O; Inoue M
    Int J Urol; 2020 Mar; 27(3):206-212. PubMed ID: 31916319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Toyoshima Y; Hara T; Matsui Y; Nagumo Y; Maejima A; Shinoda Y; Komiyama M; Watanabe SI; Fujimoto H
    Ann Surg Oncol; 2018 Nov; 25(12):3668-3675. PubMed ID: 30191415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
    Bilen MA; Hess KR; Campbell MT; Wang J; Broaddus RR; Karam JA; Ward JF; Wood CG; Choi SL; Rao P; Zhang M; Naing A; General R; Cauley DH; Lin SH; Logothetis CJ; Pisters LL; Tu SM
    Oncotarget; 2016 Dec; 7(52):86280-86289. PubMed ID: 27861143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults.
    Gilligan TD
    J Clin Oncol; 2023 Aug; 41(23):3899-3904. PubMed ID: 37410968
    [No Abstract]   [Full Text] [Related]  

  • 10. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
    Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer. A prospective study.
    Javadpour N; Young JD
    Urology; 1992 Jul; 40(1):7-8. PubMed ID: 1320303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyotyping and DNA flow cytometry of mature residual teratoma after intensive chemotherapy of disseminated nonseminomatous germ cell tumor of the testis: a report of two cases.
    Oosterhuis JW; de Jong B; Cornelisse CJ; Molenaar IM; Meiring A; Idenburg V; Koops HS; Sleijfer DT
    Cancer Genet Cytogenet; 1986 Jun; 22(2):149-57. PubMed ID: 3011241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?
    Stomper PC; Kalish LA; Garnick MB; Richie JP; Kantoff PW
    Radiology; 1991 Sep; 180(3):711-4. PubMed ID: 1651526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis.
    Lorigan JG; Eftekhari F; David CL; Shirkhoda A
    AJR Am J Roentgenol; 1988 Aug; 151(2):325-9. PubMed ID: 2839969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors.
    Green DB; La Rosa FG; Craig PG; Khani F; Lam ET
    Korean J Radiol; 2021 Oct; 22(10):1650-1657. PubMed ID: 34402242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.
    Masterson TA; Shayegan B; Carver BS; Bajorin DF; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2012 Jan; 79(1):156-9. PubMed ID: 22202548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin.
    Schirren J; Trainer S; Eberlein M; Lorch A; Beyer J; Bölükbas S
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):405-12. PubMed ID: 22383152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful resection of massively enlarged residual pulmonary metastases from a nonseminomatous germ cell testicular tumor.
    Nishida T; Nishiyama N; Inoue K; Kawata Y; Ichikawa T; Tsukioka T; Wakasa T; Wakasa K; Suehiro S
    Osaka City Med J; 2006 Dec; 52(2):87-92. PubMed ID: 17330397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
    Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Toner GC; Schraffordt Koops H; Mulders PF; Messemer JE; Ney K; Donohue JP
    J Clin Oncol; 1995 May; 13(5):1177-87. PubMed ID: 7537801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.